FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116742432> ?p ?o ?g. }

• W2116742432 endingPage "356" @default.
• W2116742432 startingPage "356" @default.
• W2116742432 abstract "Testicular cancers constitute major therapeutic challenges in resource-limited countries and still carry poor outcomes. There is a paucity of published data regarding testicular cancer in Tanzania, and Bugando Medical Centre in particular. This study describes the clinicopathological pattern, treatment outcome and challenges in the management of testicular cancer in our local setting. This was a retrospective study including all patients who had had histopathologically confirmed testicular cancer at Bugando Medical Centre between February 2004 and January 2014. A total of 56 testicular cancer patients were enrolled in the study, representing 0.9% of all malignancies. The median age of patients at presentation was 28 years, with a peak incidence in the 21-to-30-year age group. A family history of testicular cancer was reported in four (5.4%) patients. A history of cryptorchidism was reported in six (10.7%) patients. Most patients (57.1%) presented late with an advanced stage of cancer. Testicular swelling was the main complaint in 48 (85.7%) patients. The right testis was involved in 67.9% of cases. Lymph node and distant metastases were documented in 10 (17.9%) and 12 (21.4%) patients, respectively. Histologically, 80.4% of patients had germ cell cancers, with seminoma accounting for 62.2% of cases. The most common surgical procedure was inguinal orchidectomy (77.4%). Adjuvant chemotherapy and radiotherapy were used in six (11.1%) and four (7.4%) patients, respectively. Eight (14.3%) patients died. The main predictors of mortality (P < 0.001) were patient’s age (>65 years), late presentation (>6 months), stage of disease, and presence of metastasis at time of diagnosis. The mean follow-up period was 22 months. At the end of five years, only 18 (37.5%) patients were available for follow-up and the overall 5-year survival rate was 22.2%. The main predictors of 5-year survival rate (P < 0.001) were patients’ age, stage of disease, and presence of lymph node and distant metastases. Testicular cancers, though rare in our setting, still carries a poor prognosis. Late presentation, poverty, paucity of resources and the high cost of newer imaging and treatment modalities are major challenges to management. Better health funding and education regarding testicular self-examination is essential." @default.
• W2116742432 created "2016-06-24" @default.
• W2116742432 creator A5011354081 @default.
• W2116742432 creator A5037251780 @default.
• W2116742432 creator A5038660259 @default.
• W2116742432 date "2014-01-01" @default.
• W2116742432 modified "2023-09-26" @default.
• W2116742432 title "Ten-year experience with testicular cancer at a tertiary care hospital in a resource-limited setting: a single centre experience in Tanzania" @default.
• W2116742432 cites W14366270 @default.
• W2116742432 cites W1682543696 @default.
• W2116742432 cites W1904455643 @default.
• W2116742432 cites W1937254250 @default.
• W2116742432 cites W1964783858 @default.
• W2116742432 cites W1967303537 @default.
• W2116742432 cites W1984290077 @default.
• W2116742432 cites W1986538990 @default.
• W2116742432 cites W1989580313 @default.
• W2116742432 cites W1997847201 @default.
• W2116742432 cites W2011502151 @default.
• W2116742432 cites W2016394144 @default.
• W2116742432 cites W2039086202 @default.
• W2116742432 cites W2039945054 @default.
• W2116742432 cites W2046031589 @default.
• W2116742432 cites W2069171939 @default.
• W2116742432 cites W2086752812 @default.
• W2116742432 cites W2088412437 @default.
• W2116742432 cites W2094037513 @default.
• W2116742432 cites W2102443531 @default.
• W2116742432 cites W2105343189 @default.
• W2116742432 cites W2115709003 @default.
• W2116742432 cites W2137517608 @default.
• W2116742432 cites W2140211014 @default.
• W2116742432 cites W2263202489 @default.
• W2116742432 cites W2278252222 @default.
• W2116742432 cites W2414541003 @default.
• W2116742432 cites W2415753173 @default.
• W2116742432 cites W2415970103 @default.
• W2116742432 cites W2464784381 @default.
• W2116742432 cites W4250831078 @default.
• W2116742432 doi "https://doi.org/10.1186/1477-7819-12-356" @default.
• W2116742432 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4258266" @default.
• W2116742432 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25418694" @default.
• W2116742432 hasPublicationYear "2014" @default.
• W2116742432 type Work @default.
• W2116742432 sameAs 2116742432 @default.
• W2116742432 citedByCount "13" @default.
• W2116742432 countsByYear W21167424322016 @default.
• W2116742432 countsByYear W21167424322017 @default.
• W2116742432 countsByYear W21167424322019 @default.
• W2116742432 countsByYear W21167424322020 @default.
• W2116742432 countsByYear W21167424322021 @default.
• W2116742432 countsByYear W21167424322023 @default.
• W2116742432 crossrefType "journal-article" @default.
• W2116742432 hasAuthorship W2116742432A5011354081 @default.
• W2116742432 hasAuthorship W2116742432A5037251780 @default.
• W2116742432 hasAuthorship W2116742432A5038660259 @default.
• W2116742432 hasBestOaLocation W21167424321 @default.
• W2116742432 hasConcept C120665830 @default.
• W2116742432 hasConcept C121332964 @default.
• W2116742432 hasConcept C121608353 @default.
• W2116742432 hasConcept C126322002 @default.
• W2116742432 hasConcept C2776212926 @default.
• W2116742432 hasConcept C2776694085 @default.
• W2116742432 hasConcept C2777180808 @default.
• W2116742432 hasConcept C2778074268 @default.
• W2116742432 hasConcept C2778527826 @default.
• W2116742432 hasConcept C2779511695 @default.
• W2116742432 hasConcept C2780140570 @default.
• W2116742432 hasConcept C29456083 @default.
• W2116742432 hasConcept C509974204 @default.
• W2116742432 hasConcept C61434518 @default.
• W2116742432 hasConcept C61511704 @default.
• W2116742432 hasConcept C71924100 @default.
• W2116742432 hasConceptScore W2116742432C120665830 @default.
• W2116742432 hasConceptScore W2116742432C121332964 @default.
• W2116742432 hasConceptScore W2116742432C121608353 @default.
• W2116742432 hasConceptScore W2116742432C126322002 @default.
• W2116742432 hasConceptScore W2116742432C2776212926 @default.
• W2116742432 hasConceptScore W2116742432C2776694085 @default.
• W2116742432 hasConceptScore W2116742432C2777180808 @default.
• W2116742432 hasConceptScore W2116742432C2778074268 @default.
• W2116742432 hasConceptScore W2116742432C2778527826 @default.
• W2116742432 hasConceptScore W2116742432C2779511695 @default.
• W2116742432 hasConceptScore W2116742432C2780140570 @default.
• W2116742432 hasConceptScore W2116742432C29456083 @default.
• W2116742432 hasConceptScore W2116742432C509974204 @default.
• W2116742432 hasConceptScore W2116742432C61434518 @default.
• W2116742432 hasConceptScore W2116742432C61511704 @default.
• W2116742432 hasConceptScore W2116742432C71924100 @default.
• W2116742432 hasIssue "1" @default.
• W2116742432 hasLocation W21167424321 @default.
• W2116742432 hasLocation W21167424322 @default.
• W2116742432 hasLocation W21167424323 @default.
• W2116742432 hasLocation W21167424324 @default.
• W2116742432 hasOpenAccess W2116742432 @default.
• W2116742432 hasPrimaryLocation W21167424321 @default.
• W2116742432 hasRelatedWork W1539785721 @default.
• W2116742432 hasRelatedWork W1967704741 @default.

• next